Related Articles
Salidroside prevents tumor necrosis factor‑α‑induced vascular inflammation by blocking mitogen‑activated protein kinase and NF‑κB signaling activation
Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways
MicroRNA‑21 mediates the protective effects of salidroside against hypoxia/reoxygenation‑induced myocardial oxidative stress and inflammatory response
Salidroside mediates apoptosis and autophagy inhibition in concanavalin A‑induced liver injury
Neuroprotective effects of salidroside administration in a mouse model of Alzheimer's disease